Volume 26, Issue 8
August 2024
Cover image
Cover image
Figure 4 of the article by Rahman and Shi et al. “DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology” beginning on p. 1378.
ISSN 1522-8517
EISSN 1523-5866
Issue navigation
Volume 26, Issue 8, August 2024
Letter to the Editor
Ongoing expansion of journal activities to meet the needs of stakeholders
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1353–1354, https://doi.org/10.1093/neuonc/noae117
Breaking News Editorial
Shaping the future of molecular neurosurgery: Toward epigenetic precision in surgical neuro-oncology?
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1355–1356, https://doi.org/10.1093/neuonc/noae100
Consensus Reviews
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1357–1366, https://doi.org/10.1093/neuonc/noae074
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1367–1387, https://doi.org/10.1093/neuonc/noae072
Basic and Translational Investigations
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1388–1401, https://doi.org/10.1093/neuonc/noae036
Unraveling the hypoxic puzzle: LncRNA LUCAT1 drives glioblastoma in cooperation with HIF1α
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1402–1404, https://doi.org/10.1093/neuonc/noae096
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1405–1420, https://doi.org/10.1093/neuonc/noae040
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1421–1437, https://doi.org/10.1093/neuonc/noae059
Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1438–1452, https://doi.org/10.1093/neuonc/noae065
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1453–1466, https://doi.org/10.1093/neuonc/noae085
For the podcast associated with this article, please visit ‘https://soc-neuro-onc.libsyn.com/immunotherapy-drives-mesenchymal-shift-in-gbm’
Clinical Neuro-Oncology
Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1467–1478, https://doi.org/10.1093/neuonc/noae035
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1479–1493, https://doi.org/10.1093/neuonc/noae061
Diffuse midline (H3 K27M-mutant) glioma in adults—When resection fails to matter
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1494–1495, https://doi.org/10.1093/neuonc/noae099
Pediatric Neuro-Oncology
NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1496–1508, https://doi.org/10.1093/neuonc/noae054
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1509–1525, https://doi.org/10.1093/neuonc/noae066
Neuroimaging
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1526–1535, https://doi.org/10.1093/neuonc/noae067
Letter to the Editors
Tumor growth in recurrent glioblastoma—RANO: when to plan the baseline scan?
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1536–1537, https://doi.org/10.1093/neuonc/noae095
The Sybil prophecy: Searching for predictors of response to bevacizumab in glioblastoma
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1538–1539, https://doi.org/10.1093/neuonc/noae088
Sex differences in glioblastoma based on tumor subtypes
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1540–1541, https://doi.org/10.1093/neuonc/noae089
Society News
Forthcoming Meetings
Neuro-Oncology, Volume 26, Issue 8, August 2024, Page 1542, https://doi.org/10.1093/neuonc/noae110
